^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    gevokizumab (VPM087)

    i
    Associations
    News
    Trials
    Company:
    Novartis, Xoma
    Drug class:
    IL-1β inhibitor
    Related drugs:
    Associations
    News
    Trials